These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1. [Use of beta-blockader visken in children with primary arterial hypertension]. Nadezhdina EA; Vul'fson IN; Ivanitskaia IN; Kurbatov VS; Kupriianova OO Kardiologiia; 1976 May; 16(5):71-5. PubMed ID: 7701 [TBL] [Abstract][Full Text] [Related]
2. [State of the sympathetic-adrenal system and renin activity in the blood in children with primary arterial hypertension in the process of beta-blockader treatment]. Nebol'sina LI; Pinelis VG; Kurbatov VS; Nadezhdina EA; Markov KhM Kardiologiia; 1978 Nov; 18(11):38-42. PubMed ID: 31507 [TBL] [Abstract][Full Text] [Related]
3. [Change in the central and regional (brain) hemodynamics in the treatment of hypertension using beta-adrenergic blockaders]. Erina EV; Basishvili NZ; Elizarova NA; Kheĭmets GI Kardiologiia; 1976 Jul; 16(7):82-7. PubMed ID: 10464 [TBL] [Abstract][Full Text] [Related]
4. [Use of Visken-15 for treating hypertension]. Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668 [TBL] [Abstract][Full Text] [Related]
5. [Characteristics of the cardiovascular system reaction in children with arterial hypertension to the use of the Soviet beta-blockader, anaprilin]. Nadezhdina EA; Kurbatov VS; Golov AG; Kupriianova OO Pediatriia; 1980 Apr; (4):33-6. PubMed ID: 6104324 [No Abstract] [Full Text] [Related]
6. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension]. Erina EV; Basishvili NZ Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351 [TBL] [Abstract][Full Text] [Related]
7. [Hemo- and cardiodynamic changes in arterial hypertension patients as affected by alpha- and beta-adrenergic blockader therapy]. Zonis BIa Kardiologiia; 1981 Mar; 21(3):28-32. PubMed ID: 6112285 [TBL] [Abstract][Full Text] [Related]
8. [The use of the cardioselective adrenergic beta 1-blockader cordanum in the treatment of arterial hypertension]. Zonis BIa; Brin VB Ter Arkh; 1983; 55(5):81-3. PubMed ID: 6137077 [No Abstract] [Full Text] [Related]
9. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension]. Savenkov PM; Doshitsin VL; Grudtsyn GV Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799 [TBL] [Abstract][Full Text] [Related]
10. [Effect of beta-adrenergic blockaders and their combination with an alpha-adrenergic blockader on physical exertion tolerance in patients with hypertension]. Smirnov GB Kardiologiia; 1986 Mar; 26(3):33-6. PubMed ID: 2872358 [TBL] [Abstract][Full Text] [Related]
11. [The characteristics of using visken in middle-aged and elderly patients with arterial hypertension]. Tokar AV; Iena LM; Kozymenko TM; Shyshkina OS Lik Sprava; 1993; (10-12):34-8. PubMed ID: 8030304 [TBL] [Abstract][Full Text] [Related]
12. [Determination of the individual changes in cardiovascular system reactivity in prescribing adrenergic blockaders]. Paleev NR; Kaevitser IM; Kublanov LA Kardiologiia; 1977 Nov; 17(11):103-8. PubMed ID: 23449 [TBL] [Abstract][Full Text] [Related]
13. [Hemodynamics in children with primary arterial hypertension in the process of treating them with beta-adrenoblockaders and electrosleep]. Oskolkova MK; Kupriianova OO Vopr Okhr Materin Det; 1979 Jul; 24(7):14-8. PubMed ID: 43024 [No Abstract] [Full Text] [Related]
14. [Therapeutic effect of trandat, an alpha- and beta-adrenergic receptor blockader, and its effect on central, regional and intracardiac hemodynamics]. Erina EV; Charyev KhE; Beliakova EV; Tverskaia LV; Kukharchuk VV Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(1):68-74. PubMed ID: 6124260 [TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the effectiveness of the long-term treatment of hypertension patients. I. Changes in hemodynamics and myocardial function]. Erina EV; Charyev KhE Ter Arkh; 1984; 56(9):24-30. PubMed ID: 6151257 [TBL] [Abstract][Full Text] [Related]
16. [Contractile function of the myocardium and central hemodynamics in acute myocardial infarct patients after a single intravenous injection of adrenergic beta receptor blockaders]. Sandrikov VA; Iakovlev VF; Seleznev MN; Maglakelidze TA Kardiologiia; 1986 Sep; 26(9):20-2. PubMed ID: 2878102 [TBL] [Abstract][Full Text] [Related]
17. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers]. Gimeno JV; Martín G; Cosín J Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585 [No Abstract] [Full Text] [Related]
18. [Changes of cardio- and hemodynamics during treatment of arterial hypertension with adrenergic alpha receptor blockader pyrroxane]. Zonis BIa; Brin VB Ter Arkh; 1979; 51(11):28-30. PubMed ID: 42984 [No Abstract] [Full Text] [Related]
19. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum). Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634 [TBL] [Abstract][Full Text] [Related]
20. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension. Lund-Johansen P Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]